BioVaxys Technology Corp says the US Food and Drug Administration has provided guidance for it to prepare a Investigational New Drug (IND) application for clinical trials of CoviDTH as a diagnostic for evaluating T-cell immune response to SARS-CoV-2

BioVaxys Technology Corp says the US Food and Drug Administration has provided guidance for it to prepare a Investigational New Drug (IND) application for clinical trials of CoviDTH as a diagnostic for evaluating T-cell immune response to SARS-CoV-2

proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.